Blockade of CD155 and Interleukin-6 Suppresses Breast Cancer Cell Growth
International Journal of Drug Research in Clinics · 2023
DOI: 10.34172/ijdrc.2023.e10 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Research in Clinics, 2023. Verfasst von Atefeh Khodakarami und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
Breast cancer is the foremost common type of cancer worldwide and the leading cause of death related to cancer. Poliovirus receptor (CD155) or nectin-like molecule-5 expression has been shown to increase in tumor cells and bind to the DNAX accessory molecule (DNAM-1)/T cell immunoreceptor with Ig and ITIM domains (TIGIT)/CD69 ligand present on the surface of T and natural killer cells, increasing inflammatory cytokines, including interleukin 6 (IL-6) in the tumor microenvironment. As a result, we intended to simultaneously target both CD155 and IL-6 as an effective therapeutic approach to prevent breast cancer growth.
Methods
In this study, 4T1 cells were transfected with small interfering RNA (siRNA) molecules against CD155 and IL-6, using lipofectamine (LP). Target gene expression was analyzed using both the real-time polymerase chain reaction (RT-PCR) and an enzyme-linked immunosorbent assay (ELISA). The methyl thiazolyl tetrazolium (MTT) assay also examined the cytotoxic effect of combined therapy.
Results
The results showed that the cells were effectively transfected with LP, resulting in the downregulation of IL-6 and CD155. In addition, the combined silencing of IL-6 and CD155 potently reduced the cellular viability of cancer cells.
Conclusion
These findings revealed that the simultaneous targeting of CD155 and IL-6 in breast cancer cells (4T1) is an innovative and efficient therapy strategy to induce apoptosis in malignant cells.
Zitieren
APA
Khodakarami, A., Darvishi, S., Hassannia, H., Sadeghi, M., Esmaeeli, S., Hashemi, V., Hojjat-Farsangi, M., & Jadidi-Niaragh, F. (2023). Blockade of CD155 and Interleukin-6 Suppresses Breast Cancer Cell Growth. International Journal of Drug Research in Clinics. https://doi.org/10.34172/ijdrc.2023.e10
Vancouver
Khodakarami A, Darvishi S, Hassannia H, Sadeghi M, Esmaeeli S, Hashemi V, et al. Blockade of CD155 and Interleukin-6 Suppresses Breast Cancer Cell Growth. International Journal of Drug Research in Clinics. 2023. doi:10.34172/ijdrc.2023.e10
BibTeX
@article{Khodakarami2023,
author = {Khodakarami, Atefeh and Darvishi, Samira and Hassannia, Hadi and Sadeghi, Mohammad and Esmaeeli, Sana and Hashemi, Vida and Hojjat-Farsangi, Mohammad and Jadidi-Niaragh, Farhad},
title = {Blockade of CD155 and Interleukin-6 Suppresses Breast Cancer Cell Growth},
journal = {International Journal of Drug Research in Clinics},
year = {2023},
doi = {10.34172/ijdrc.2023.e10}
}
EUVIMED